What's new

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Mar 11, 2025 - 14:47
 0
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

CDMO Almac continues expansion spree with new £65M UK oral treatment plant

Next Article

Kroger bets big on private brands

Related Posts

Combination of cystic fibrosis medicines to treat patients with rare mutations

Combination of cystic fibrosis medicines to treat patie...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Info session on web-based electronic Application Form (eAF) add package, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 July 2024, 11:00 (CEST) to 18 July 2024, 12:00 (CEST)

Info session on web-based electronic Application Form (...

Mar 7, 2025  0